117 related articles for article (PubMed ID: 29024707)
1. Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
Zhou L; Gao HF; Liu DS; Feng JY; Gao DD; Xia W
Gene; 2018 Jan; 640():21-27. PubMed ID: 29024707
[TBL] [Abstract][Full Text] [Related]
2. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
Guo J; Gong G; Zhang B
Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
[TBL] [Abstract][Full Text] [Related]
4. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
6. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
[TBL] [Abstract][Full Text] [Related]
7. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
9. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
10. Brain-metastatic triple-negative breast cancer cells regain growth ability by altering gene expression patterns.
Choi YK; Woo SM; Cho SG; Moon HE; Yun YJ; Kim JW; Noh DY; Jang BH; Shin YC; Kim JH; Shin HD; Paek SH; Ko SG
Cancer Genomics Proteomics; 2013; 10(6):265-75. PubMed ID: 24336635
[TBL] [Abstract][Full Text] [Related]
11. Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.
Yang F; Liu YH; Dong SY; Yao ZH; Lv L; Ma RM; Dai XX; Wang J; Zhang XH; Wang OC
Gene; 2016 Oct; 591(2):471-7. PubMed ID: 27380926
[TBL] [Abstract][Full Text] [Related]
12. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
13. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
[TBL] [Abstract][Full Text] [Related]
14. Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
Duchnowska R; Jarząb M; Żebracka-Gala J; Matkowski R; Kowalczyk A; Radecka B; Kowalska M; Pfeifer A; Foszczyńska-Kłoda M; Musolino A; Czartoryska-Arłukowicz B; Litwiniuk M; Surus-Hyla A; Szabłowska-Siwik S; Karczmarek-Borowska B; Dębska-Szmich S; Głodek-Sutek B; Sosińska-Mielcarek K; Chmielowska E; Kalinka-Warzocha E; Olszewski WP; Patera J; Żawrocki A; Pliszka A; Tyszkiewicz T; Rusinek D; Oczko-Wojciechowska M; Jassem J; Biernat W;
Clin Breast Cancer; 2017 Apr; 17(2):e65-e75. PubMed ID: 27692773
[TBL] [Abstract][Full Text] [Related]
15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
16. Novel genes associated with lymph node metastasis in triple negative breast cancer.
Mathe A; Wong-Brown M; Morten B; Forbes JF; Braye SG; Avery-Kiejda KA; Scott RJ
Sci Rep; 2015 Nov; 5():15832. PubMed ID: 26537449
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of the potential roles of miRNA‑mRNA networks in triple negative breast cancer.
Zhu H; Dai M; Chen X; Chen X; Qin S; Dai S
Mol Med Rep; 2017 Aug; 16(2):1139-1146. PubMed ID: 28627677
[TBL] [Abstract][Full Text] [Related]
18. MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.
Zheng M; Wu Z; Wu A; Huang Z; He N; Xie X
Tumour Biol; 2016 Jul; 37(7):8599-607. PubMed ID: 26733177
[TBL] [Abstract][Full Text] [Related]
19. Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer.
Goode G; Pratap S; Eltom SE
PLoS One; 2014; 9(6):e100103. PubMed ID: 24932473
[TBL] [Abstract][Full Text] [Related]
20. Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems.
Mudvari P; Ohshiro K; Nair V; Horvath A; Kumar R
PLoS One; 2013; 8(9):e74993. PubMed ID: 24086418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
